Ebola vaccines: Keep the clinical trial protocols on the shelf and ready to roll out

The Lancet

Volumn 385, Issue 9980, 2015, Pages 1913-1915

  Heymann, David L ^a,b   Rodier, Guenael R ^c   Ryan, Michael J ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL INSTITUTE OF INTERNATIONAL AFFAIRS   (United Kingdom)

^c WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

BIOLOGICAL WARFARE; CENTRAL AFRICA; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EBOLA HEMORRHAGIC FEVER; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; NONHUMAN; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRUS TRANSMISSION; AFRICA; DRUG APPROVAL; EPIDEMIC; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES;

AFRICA, WESTERN; CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; DRUG APPROVAL; EBOLA VACCINES; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNIZATION PROGRAMS;

EID: 84929507590     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60645-6     Document Type: Note

References (11)

1. G Maganga, J Kapetshi, N Berthet et al. Ebola virus disease in the Democratic Republic of Congo N Engl J Med 371 2014 2083 2091
2. M Lamunu, J Lutwama, J Kamugisha et al. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001) Int J Infect Dis 8 2004 27 37
3. A Khan, F Tshioko, D Heymann et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995 J Infect Dis 179 suppl 1 1999 S76 S86
4. Report of an International Commission Ebola haemorrhagic fever in Zaire, 1976 Bull World Health Organ 56 1978 271 293
5. Z Jezek, M Szczeniowski, J Muyembe-Tamfum, J McCormick, D Heymann Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985 J Infect Dis 179 suppl 1 1999 S60 S64
6. D Heymann, J Weisfeld, P Webb, K Johnson, T Cairns, H Berquist Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978 J Infect Dis 142 1999 372 376
7. WHO WHO Ebola R&D effort - vaccines, therapies, diagnostics http://www.who.int/medicines/ebola-treatment/ebola-r-d-effort/en/ 2015 (accessed Feb 23, 2015).
8. GAVI Vaccine Alliance Gavi commits to purchasing Ebola vaccine for affected countries http://www.gavi.org/Library/News/Press-releases/2014/Gavi-commits-to-purchasing-ebola-vaccine-for-affected-countries/ Dec 11, 2014 (accessed Feb 23, 2015).
9. Wellcome Trust Recommendations for accelerating the development of Ebola vaccines http://www.wellcome.ac.uk/News/Media-office/Press-releases/2015/WTP058692.htm Feb 17, 2015 (accessed March 26, 2015).
10. WHO Recommendations for the production and quality control of smallpox vaccine, revised 2003. WHO Technical Report Series 926, annex 1 2004 World Health Organization Geneva
11. FJ Cassels Severe acute respiratory syndrome. The Jordan Report 2012 2012 National Institute of Allergy and Infectious Diseases Bethesda, MD 98 104